CLYM PT raised by Baird; maintained Outperform
Baird maintained an Outperform rating on Clym Bio and raised its price target to $25.00 per share from $21.00, per TradingView News/Benzinga.
Ratings actions GMT) Climb Bio Price Target Raised to $25.00/Share From $21.00 by BairdRatings actions